152 related articles for article (PubMed ID: 29030227)
1. Exploring the feasibility of obtaining mifepristone and misoprostol from the internet.
Murtagh C; Wells E; Raymond EG; Coeytaux F; Winikoff B
Contraception; 2018 Apr; 97(4):287-291. PubMed ID: 29030227
[TBL] [Abstract][Full Text] [Related]
2. Cost of goods sold analysis and recommendations to reduce costs of co-packaged mifepristone-misoprostol for medical abortion.
Chinery L; Allaouidine C; Tomazzini A; Larson M; Gülmezoglu AM
Reprod Health; 2020 Nov; 17(1):171. PubMed ID: 33148282
[TBL] [Abstract][Full Text] [Related]
3. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Gomperts RJ; Jelinska K; Davies S; Gemzell-Danielsson K; Kleiverda G
BJOG; 2008 Aug; 115(9):1171-5; discussion 1175-8. PubMed ID: 18637010
[TBL] [Abstract][Full Text] [Related]
4. A descriptive analysis of medical abortion commodity availability and pricing at retail outlets in 44 countries across four regions globally.
Durocher J; Kilfedder C; Frye LJ; Winikoff B; Srinivasan K
Sex Reprod Health Matters; 2021 Dec; 29(1):1982460. PubMed ID: 34719353
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of misoprostol and cervagem in combination with a reduced dose of mifepristone for induction of abortion.
Baird DT; Sukcharoen N; Thong KJ
Hum Reprod; 1995 Jun; 10(6):1521-7. PubMed ID: 7593528
[TBL] [Abstract][Full Text] [Related]
6. Comparing two early medical abortion regimens: mifepristone+misoprostol vs. misoprostol alone.
Ngoc NT; Blum J; Raghavan S; Nga NT; Dabash R; Diop A; Winikoff B
Contraception; 2011 May; 83(5):410-7. PubMed ID: 21477682
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of medical abortion using mifepristone and buccal misoprostol through 63 days.
Gatter M; Cleland K; Nucatola DL
Contraception; 2015 Apr; 91(4):269-73. PubMed ID: 25592080
[TBL] [Abstract][Full Text] [Related]
8. Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Gomperts R; Kleiverda G; Gemzell K; Davies S; Jelinska K
BJOG; 2008 Nov; 115(12):1578-9. PubMed ID: 19035995
[No Abstract] [Full Text] [Related]
9. The true cost differential between mifepristone and misoprostol and misoprostol-alone regimens for medical abortion.
Creinin MD; Shore E; Balasubramanian S; Harwood B
Contraception; 2005 Jan; 71(1):26-30. PubMed ID: 15639068
[TBL] [Abstract][Full Text] [Related]
10. Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.
Afifi M; Hemachandra N; Sikandar Q; Hajjeh R; Loi UR; Läser L; Qato D; Abdul ZS; Chikvaidze P; Abbas RAR; Al-Kinani K; Hasan H; El-Kak F; Rady A; Brngali O; Hashem M; Bezad R; Amine C; Hafid H; Afzal S; Zaidi R; Thom E; Uzma Q; Al-Masri H; Qamar ZA; Ghanem B; Ward IA; Shaar AN; Farah U; Mohamed YO; Umar AU; Eladawy M
Reprod Health; 2024 Jun; 20(Suppl 1):192. PubMed ID: 38835050
[TBL] [Abstract][Full Text] [Related]
11. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan.
Raghavan S; Tsereteli T; Kamilov A; Kurbanbekova D; Yusupov D; Kasimova F; Jymagylova D; Winikoff B
Eur J Contracept Reprod Health Care; 2013 Apr; 18(2):104-11. PubMed ID: 23387475
[TBL] [Abstract][Full Text] [Related]
12. Medical methods for first trimester abortion.
Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
[TBL] [Abstract][Full Text] [Related]
13. Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion.
Winikoff B; Sivin I; Coyaji KJ; Cabezas E; Xiao B; Gu S; Du MK; Krishna UR; Eschen A; Ellertson C
Am J Obstet Gynecol; 1997 Feb; 176(2):431-7. PubMed ID: 9065194
[TBL] [Abstract][Full Text] [Related]
14. Mifepristone by prescription: a dream in the United States but reality in Australia.
Grossman D; Goldstone P
Contraception; 2015 Sep; 92(3):186-9. PubMed ID: 26096369
[TBL] [Abstract][Full Text] [Related]
15. Early pregnancy termination with intravaginally administered sodium chloride solution-moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol.
Jain JK; Meckstroth KR; Mishell DR
Am J Obstet Gynecol; 1999 Dec; 181(6):1386-91. PubMed ID: 10601917
[TBL] [Abstract][Full Text] [Related]
16. Quality testing of mifepristone and misoprostol in 11 countries.
Bower J; Chinery L; Fleurent A; Gülmezoglu AM; Im-Amornphong W; Kilfedder C; Procter P; Tomazzini A
Int J Gynaecol Obstet; 2024 May; 165(2):405-415. PubMed ID: 37775986
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of different buccal misoprostol doses in mifepristone medical abortion.
Chong E; Tsereteli T; Nguyen NN; Winikoff B
Contraception; 2012 Sep; 86(3):251-6. PubMed ID: 22305917
[TBL] [Abstract][Full Text] [Related]
18. Online access to abortion medications: a review of utilization and clinical outcomes.
Endler M; Cleeve A; Gemzell-Danielsson K
Best Pract Res Clin Obstet Gynaecol; 2020 Feb; 63():74-86. PubMed ID: 31383555
[TBL] [Abstract][Full Text] [Related]
19. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India.
Ganatra B; Manning V; Pallipamulla SP
Reprod Health Matters; 2005 Nov; 13(26):65-74. PubMed ID: 16291487
[TBL] [Abstract][Full Text] [Related]
20. Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
Haldane J
BJOG; 2008 Nov; 115(12):1587-8; author reply 1588-9. PubMed ID: 19054856
[No Abstract] [Full Text] [Related]
[Next] [New Search]
